- Home
- HYFM vs SABS Comparison
HYFM vs SABS Comparison
Compare HYFM & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYFM
- SABS
- Stock Information
- Founded
- HYFM 1977
- SABS 2014
- Country
- HYFM United States
- SABS United States
- Employees
- HYFM N/A
- SABS N/A
- Industry
- HYFM Industrial Machinery/Components
- SABS Biotechnology: Pharmaceutical Preparations
- Sector
- HYFM Industrials
- SABS Health Care
- Exchange
- HYFM Nasdaq
- SABS Nasdaq
- Market Cap
- HYFM 22.8M
- SABS 19.0M
- IPO Year
- HYFM 2020
- SABS N/A
- Fundamental
- Price
- HYFM $2.15
- SABS $1.25
- Analyst Decision
- HYFM Hold
- SABS Strong Buy
- Analyst Count
- HYFM 2
- SABS 5
- Target Price
- HYFM $7.00
- SABS $11.40
- AVG Volume (30 Days)
- HYFM 26.6K
- SABS 38.1K
- Earning Date
- HYFM 05-13-2025
- SABS 05-19-2025
- Dividend Yield
- HYFM N/A
- SABS N/A
- EPS Growth
- HYFM N/A
- SABS N/A
- EPS
- HYFM N/A
- SABS N/A
- Revenue
- HYFM $190,288,000.00
- SABS $1,322,410.00
- Revenue This Year
- HYFM $5.45
- SABS N/A
- Revenue Next Year
- HYFM $5.33
- SABS $25.00
- P/E Ratio
- HYFM N/A
- SABS N/A
- Revenue Growth
- HYFM N/A
- SABS N/A
- 52 Week Low
- HYFM $1.83
- SABS $1.11
- 52 Week High
- HYFM $12.00
- SABS $5.01
- Technical
- Relative Strength Index (RSI)
- HYFM 23.53
- SABS 31.17
- Support Level
- HYFM $1.83
- SABS $1.11
- Resistance Level
- HYFM $2.32
- SABS $1.80
- Average True Range (ATR)
- HYFM 0.24
- SABS 0.16
- MACD
- HYFM 0.01
- SABS -0.01
- Stochastic Oscillator
- HYFM 17.85
- SABS 18.42
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.